The latest trading session saw Abbott (ABT) ending at $132.65, denoting a +1.4% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a gain of 0.55% for the day.

"We are just at the beginning of a very exciting era," says Aerogen Director of R&D, Science and Emerging Technologies Ronan ...

All malaria rapid diagnostic tests have been implicated in the WHO product alert, as manufacturer investigations continue.

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

Abbott (ABT) announced late-breaking data from its Triluminate Pivotal trial that show the TriClip transcatheter edge-to-edge repair system to ...

Bioelectronic devices, neural interfaces, biosensors and AI hardware are now easier to make thanks to a streamlined method for fabricating a key material.

For any parent, the arrival of a new baby is joyful. But for a Hanover, Minnesota, family, a prenatal checkup turned into ...

We recently published a list of the 10 Best S&P 500 Stocks to Buy for Dividend Growth. In this article, we are going to take ...

Nearly 70% of people with diabetes believe there is stigma associated with their condition, according to a survey from Abbott ...

Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe. The CE mark is an affirmation by a product's manufacturer that it ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...